SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-22-095210
Filing Date
2022-08-26
Accepted
2022-08-26 17:16:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2224638d1_sc13da.htm SC 13D/A 46113
  Complete submission text file 0001104659-22-095210.txt   47695
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Subject) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-79901 | Film No.: 221206200
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 PARK PLAZA THIRD FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA THIRD FLOOR BOSTON MA 02116 2062185982
Life Biosciences LLC (Filed by) CIK: 0001751806 (see all company filings)

IRS No.: 822142145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A